ES3041328T3 - Crystal forms of glp-1r agonists and uses thereof - Google Patents

Crystal forms of glp-1r agonists and uses thereof

Info

Publication number
ES3041328T3
ES3041328T3 ES21798552T ES21798552T ES3041328T3 ES 3041328 T3 ES3041328 T3 ES 3041328T3 ES 21798552 T ES21798552 T ES 21798552T ES 21798552 T ES21798552 T ES 21798552T ES 3041328 T3 ES3041328 T3 ES 3041328T3
Authority
ES
Spain
Prior art keywords
compound
crystalline form
peaks
disease
diabetes
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
ES21798552T
Other languages
English (en)
Spanish (es)
Inventor
Wenge Zhong
Wei Guo
Zheng Jane Li
Xiawei Jiang
Pengyuan Chen
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Qilu Regor Therapeutics Inc
Original Assignee
Qilu Regor Therapeutics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Qilu Regor Therapeutics Inc filed Critical Qilu Regor Therapeutics Inc
Application granted granted Critical
Publication of ES3041328T3 publication Critical patent/ES3041328T3/es
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00—Indexing scheme relating to specific properties of organic compounds
    • C07B2200/13—Crystalline forms, e.g. polymorphs

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Diabetes (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
ES21798552T 2020-10-14 2021-10-13 Crystal forms of glp-1r agonists and uses thereof Active ES3041328T3 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CN2020120814 2020-10-14
PCT/CN2021/123387 WO2022078352A1 (en) 2020-10-14 2021-10-13 Crystal forms of glp-1r agonists and uses thereof

Publications (1)

Publication Number Publication Date
ES3041328T3 true ES3041328T3 (en) 2025-11-11

Family

ID=78401981

Family Applications (1)

Application Number Title Priority Date Filing Date
ES21798552T Active ES3041328T3 (en) 2020-10-14 2021-10-13 Crystal forms of glp-1r agonists and uses thereof

Country Status (9)

Country Link
US (1) US12516041B2 (https=)
EP (1) EP4228753B1 (https=)
JP (1) JP7769695B2 (https=)
CN (1) CN116710446B (https=)
AU (1) AU2021359493A1 (https=)
CA (1) CA3195264A1 (https=)
ES (1) ES3041328T3 (https=)
TW (1) TWI912388B (https=)
WO (1) WO2022078352A1 (https=)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20210069000A (ko) * 2019-12-02 2021-06-10 현대약품 주식회사 Glp-1 수용체 작용제
KR20240068737A (ko) 2021-09-27 2024-05-17 테른스 파마슈티칼스, 인크. Glp-1r 효능제로서의 벤즈이미다졸 카복실산
AU2022375634A1 (en) 2021-10-25 2024-06-06 Terns Pharmaceuticals, Inc. Compounds as glp-1r agonists
KR20240150488A (ko) 2022-02-23 2024-10-15 테른스 파마슈티칼스, 인크. Glp-1r 작용제로서의 화합물
CN117362282B (zh) * 2022-07-07 2026-04-21 杭州德睿智药科技有限公司 Glp-1r激动剂的盐及其制备方法和应用
AU2023310481A1 (en) * 2022-07-18 2025-03-06 Mindrank Therapeutics (Suzhou) New Drug Research And Development Co., Ltd Polymorphic form of glp-1r agonist, preparation method therefor and use thereof
US20240398794A1 (en) 2023-04-07 2024-12-05 Terns Pharmaceuticals, Inc. COMBINATIONS OF GLP-1R AND THRß AGONISTS AND METHODS OF USE THEREOF
TW202521533A (zh) 2023-09-14 2025-06-01 香港商歌禮製藥(中國)有限公司 Glp-1r 激動劑及其治療方法
US12291530B1 (en) 2023-11-24 2025-05-06 Ascletis Pharma (China) Co., Limited GLP-1R agonist and therapeutic method thereof

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3773919A (en) 1969-10-23 1973-11-20 Du Pont Polylactide-drug mixtures
US4485045A (en) 1981-07-06 1984-11-27 Research Corporation Synthetic phosphatidyl cholines useful in forming liposomes
US4544545A (en) 1983-06-20 1985-10-01 Trustees University Of Massachusetts Liposomes containing modified cholesterol for organ targeting
US5013556A (en) 1989-10-20 1991-05-07 Liposome Technology, Inc. Liposomes with enhanced circulation time
US7727983B2 (en) 2008-03-07 2010-06-01 Transtech Pharma, Inc. Oxadiazoanthracene compounds for the treatment of diabetes
AR083878A1 (es) * 2010-11-15 2013-03-27 Boehringer Ingelheim Int Terapia antidiabetica vasoprotectora y cardioprotectora, linagliptina, metodo de tratamiento
EP3555064B9 (en) * 2016-12-16 2023-03-01 Pfizer Inc. Glp-1 receptor agonists and uses thereof
ES2943510T3 (es) * 2018-06-15 2023-06-13 Pfizer Agonistas del receptor GLP-1 y usos del mismo
CR20210341A (es) * 2018-11-22 2021-11-25 Qilu Regor Therapeutics Inc Agonistas de glp-ir y usos de los mismos
US10954221B2 (en) * 2019-04-12 2021-03-23 Qilu Regor Therapeutics Inc. GLP-1R agonists and uses thereof
AU2020256647B2 (en) * 2019-04-12 2025-07-31 Qilu Regor Therapeutics Inc. GLP-1R agonists and uses thereof

Also Published As

Publication number Publication date
EP4228753C0 (en) 2025-07-30
JP2023546125A (ja) 2023-11-01
EP4228753B1 (en) 2025-07-30
US12516041B2 (en) 2026-01-06
WO2022078352A1 (en) 2022-04-21
CA3195264A1 (en) 2022-04-21
AU2021359493A9 (en) 2025-01-09
US20230382899A1 (en) 2023-11-30
CN116710446A (zh) 2023-09-05
TWI912388B (zh) 2026-01-21
JP7769695B2 (ja) 2025-11-13
CN116710446B (zh) 2024-10-18
AU2021359493A1 (en) 2023-06-15
TW202227421A (zh) 2022-07-16
EP4228753A1 (en) 2023-08-23

Similar Documents

Publication Publication Date Title
ES3041328T3 (en) Crystal forms of glp-1r agonists and uses thereof
ES2985435T3 (es) Formas salinas y cristalinas de agonistas de GLP-1R y sus usos
ES2934789T3 (es) Agonistas del receptor glp-1 y usos del mismo
TWI910597B (zh) 葡萄糖依賴性促胰島素多肽受體拮抗劑及其用途
US12459923B2 (en) Tetrazole containing apoptosis signal-regulating kinase 1 inhibitors and methods of use thereof
AU2023224854A1 (en) Compounds as glp-1r agonists
US20180362503A1 (en) Apoptosis signal-regulating kinase 1 inhibitors and methods of use thereof
CN113754654A (zh) 咪唑并吡啶类化合物及其用途
BR112020025701A2 (pt) Processo de produção e intermediários para um composto de pirrolo[2,3-d]pirimidina e seu uso
CN111315758B (zh) 短肽季铵盐化合物及其用途
TW202540152A (zh) 具有經修飾之離胺酸殘基之雜合肽化合物
HK40089377B (en) Crystal forms of glp-1r agonists and uses thereof
HK40089377A (en) Crystal forms of glp-1r agonists and uses thereof
TWI913272B (zh) Ｇｌｐ-１ｒ促效劑之鹽和晶型及其用途
HK40087545B (en) Salt and crystal forms of glp-1r agonists and uses thereof
HK40087545A (en) Salt and crystal forms of glp-1r agonists and uses thereof
CN104926706A (zh) 六氢并环戊二烯衍生物的盐及其制备方法和应用
BR112019012211B1 (pt) Agonistas de receptor de glp-1, composição farmacêutica que compreende os mesmos e usos dos mesmos